Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Financing Activities (2016 - 2025)

Aethlon Medical filings provide 15 years of Cash from Financing Activities readings, the most recent being $2.4 million for Q1 2025.

  • On a quarterly basis, Cash from Financing Activities rose 5441.34% to $2.4 million in Q1 2025 year-over-year; TTM through Mar 2025 was $7.7 million, a 500.14% increase, with the full-year FY2025 number at $7.7 million, up 500.14% from a year prior.
  • Cash from Financing Activities hit $2.4 million in Q1 2025 for Aethlon Medical, up from -$7073.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $17.4 million in Q2 2021 to a low of -$28134.0 in Q3 2021.
  • Median Cash from Financing Activities over the past 5 years was -$1884.0 (2022), compared with a mean of $2.1 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 29600.95% in 2022 and later plummeted 103.99% in 2024.
  • Aethlon Medical's Cash from Financing Activities stood at -$13557.0 in 2021, then skyrocketed by 86.1% to -$1884.0 in 2022, then soared by 9501.75% to $177129.0 in 2023, then tumbled by 103.99% to -$7073.0 in 2024, then soared by 33453.03% to $2.4 million in 2025.
  • The last three reported values for Cash from Financing Activities were $2.4 million (Q1 2025), -$7073.0 (Q4 2024), and -$3832.0 (Q3 2024) per Business Quant data.